---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-357463"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2021-12-15T23:59:59+00:00"
generated_at: "2026-06-28T00:59:55.085139+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics appoints Kimball Hall to board of directors

## Summary
- Kimball Hall appointed to Board effective December 10, 2021 as Class I director.
- Granted stock option for 19,850 shares vesting monthly over 3 years.
- Annual cash retainer of $35,000, pro-rated for 2021.
- Eligible for annual option grant of 9,925 shares starting 2022 annual meeting.

## SEC filing metadata
- accession: 0001193125-21-357463
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2021-12-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312521357463/0001193125-21-357463-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312521357463/d274787d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-357463
- JSON: https://secwatch.observer/filing/0001193125-21-357463.json
- Plain text: https://secwatch.observer/filing/0001193125-21-357463.txt

## Key facts
- Executive change
  Kimball Hall was appointed as Director at Vera Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: On December 10, 2021, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Kimball Hall to the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831828/000119312521357463/0001193125-21-357463-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.